INNA WEGNER: Open Payments
NPI 1023533213 · NORWOOD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,113 in 40 payments from 15 companies in 2025. Trend: 2023 $1,479 · 2024 $1,053 · 2025 $1,113
Food & beverage: $1,047Education: $66
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $223 |
| LEO Pharma Inc. | 4 | $179 |
| ABBVIE INC. | 7 | $141 |
| GENZYME CORPORATION | 3 | $116 |
| Incyte Corporation | 4 | $101 |
| UCB, Inc. | 2 | $57 |
| Organon LLC | 2 | $56 |
| Regeneron Healthcare Solutions, Inc. | 2 | $41 |
| PFIZER INC. | 2 | $41 |
| Galderma Laboratories, L.P. | 2 | $37 |
Products named: TREMFYA, ADBRY, DUPIXENT, OPZELURA, SKYRIZI, RINVOQ, Bimzelx, CIBINQO.
Industry payments across MA — which companies pay providers there.
